Literature DB >> 34999731

WTAP-mediated m6A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis.

Zhi-Xuan Li1, Zi-Qi Zheng1, Pan-Yang Yang1, Li Lin1, Guan-Qun Zhou1, Jia-Wei Lv1, Lu-Lu Zhang2, FoPing Chen1, Ying-Qin Li1, Chen-Fei Wu1, Feng Li1, Jun Ma1, Na Liu3, Ying Sun4.   

Abstract

As the most predominant RNA epigenetic regulation in eukaryotic cells, N6-methyladenosine (m6A) plays a critical role in human tumorigenesis and cancer progression. However, the biological function and molecular mechanism of m6A regulation in naso-pharyngeal carcinoma (NPC) remain elusive. Here, we showed that Wilms' tumor 1-associating protein (WTAP) expression was apparently upregulated in NPC, and increased WTAP was associated with poor prognosis. WTAP upregulated in NPC was fine-tuned by KAT3A-mediated H3K27 acetylation. Functionally, WTAP was required for the growth and metastasis of NPC. Mechanistically, lncRNA DIAPH1-AS1 was identified as a bona fide m6A target of WTAP. WTAP-mediated m6A modification of DIAPH1-AS1 enhanced its stability relying on the m6A reader IGF2BP2-dependent pathway. Furthermore, DIAPH1-AS1 acted as a molecular adaptor that promoted MTDH-LASP1 complex formation and upregulated LASP1 expression, ultimately facilitating NPC growth and metastasis. Thus, WTAP-mediated DIAPH1-AS1 m6A methylation is required for NPC tumorigenesis and metastasis.
© 2022. The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34999731      PMCID: PMC9177844          DOI: 10.1038/s41418-021-00905-w

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   12.067


  55 in total

Review 1.  Nasopharyngeal carcinoma.

Authors:  Yu-Pei Chen; Anthony T C Chan; Quynh-Thu Le; Pierre Blanchard; Ying Sun; Jun Ma
Journal:  Lancet       Date:  2019-06-06       Impact factor: 79.321

2.  Long noncoding RNA lncKdm2b is required for ILC3 maintenance by initiation of Zfp292 expression.

Authors:  Benyu Liu; Buqing Ye; Liuliu Yang; Xiaoxiao Zhu; Guanling Huang; Pingping Zhu; Ying Du; Jiayi Wu; Xiwen Qin; Runsheng Chen; Yong Tian; Zusen Fan
Journal:  Nat Immunol       Date:  2017-03-20       Impact factor: 25.606

Review 3.  Nasopharyngeal carcinoma.

Authors:  Melvin L K Chua; Joseph T S Wee; Edwin P Hui; Anthony T C Chan
Journal:  Lancet       Date:  2015-08-28       Impact factor: 79.321

Review 4.  m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer.

Authors:  Huilin Huang; Hengyou Weng; Jianjun Chen
Journal:  Cancer Cell       Date:  2020-03-16       Impact factor: 31.743

5.  Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma.

Authors:  Wei Jiang; Na Liu; Xiao-Zhong Chen; Ying Sun; Bin Li; Xian-Yue Ren; Wei-Feng Qin; Ning Jiang; Ya-Fei Xu; Ying-Qin Li; Jian Ren; William C S Cho; Jing-Ping Yun; Jing Zeng; Li-Zhi Liu; Li Li; Ying Guo; Hai-Qiang Mai; Mu-Sheng Zeng; Tie-Bang Kang; Wei-Hua Jia; Jian-Yong Shao; Jun Ma
Journal:  Mol Cancer Ther       Date:  2015-10-06       Impact factor: 6.261

6.  m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.

Authors:  Sicong Zhang; Boxuan Simen Zhao; Aidong Zhou; Kangyu Lin; Shaoping Zheng; Zhike Lu; Yaohui Chen; Erik P Sulman; Keping Xie; Oliver Bögler; Sadhan Majumder; Chuan He; Suyun Huang
Journal:  Cancer Cell       Date:  2017-03-23       Impact factor: 31.743

7.  N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential.

Authors:  Dandan Yang; Jing Qiao; Guiying Wang; Yuanyuan Lan; Guoping Li; Xudong Guo; Jiajie Xi; Dan Ye; Songcheng Zhu; Wen Chen; Wenwen Jia; Ye Leng; Xiaoping Wan; Jiuhong Kang
Journal:  Nucleic Acids Res       Date:  2018-05-04       Impact factor: 16.971

8.  m6A-mediated ZNF750 repression facilitates nasopharyngeal carcinoma progression.

Authors:  Panpan Zhang; Qiuping He; Yuan Lei; Yingqin Li; Xin Wen; Mengzhi Hong; Jian Zhang; Xianyue Ren; Yaqin Wang; Xiaojing Yang; Qingmei He; Jun Ma; Na Liu
Journal:  Cell Death Dis       Date:  2018-12-05       Impact factor: 8.469

9.  Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation.

Authors:  Huilin Huang; Hengyou Weng; Wenju Sun; Xi Qin; Hailing Shi; Huizhe Wu; Boxuan Simen Zhao; Ana Mesquita; Chang Liu; Celvie L Yuan; Yueh-Chiang Hu; Stefan Hüttelmaier; Jennifer R Skibbe; Rui Su; Xiaolan Deng; Lei Dong; Miao Sun; Chenying Li; Sigrid Nachtergaele; Yungui Wang; Chao Hu; Kyle Ferchen; Kenneth D Greis; Xi Jiang; Minjie Wei; Lianghu Qu; Jun-Lin Guan; Chuan He; Jianhua Yang; Jianjun Chen
Journal:  Nat Cell Biol       Date:  2018-02-23       Impact factor: 28.824

10.  Wilms' tumor 1-associating protein plays an aggressive role in diffuse large B-cell lymphoma and forms a complex with BCL6 via Hsp90.

Authors:  Yue Kuai; Xin Gong; Liya Ding; Fang Li; Lizhen Lei; Yuqi Gong; Qingmeng Liu; Huajiao Tan; Xinxia Zhang; Dongyu Liu; Guoping Ren; Hongyang Pan; Yaoyao Shi; Friederike Berberich-Siebelt; Zhengrong Mao; Ren Zhou
Journal:  Cell Commun Signal       Date:  2018-08-24       Impact factor: 5.712

View more
  6 in total

1.  circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA.

Authors:  Lifeng Ding; Ruyue Wang; Qiming Zheng; Danyang Shen; Huan Wang; Zeyi Lu; Wenqin Luo; Haiyun Xie; Liangliang Ren; Minxiao Jiang; Chenhao Yu; Zhenwei Zhou; Yudong Lin; Haohua Lu; Dingwei Xue; Wenjing Su; Liqun Xia; Jochen Neuhaus; Sheng Cheng; Gonghui Li
Journal:  J Exp Clin Cancer Res       Date:  2022-06-02

2.  A lncRNA signature associated with tumor immune heterogeneity predicts distant metastasis in locoregionally advanced nasopharyngeal carcinoma.

Authors:  Ye-Lin Liang; Yuan Zhang; Xi-Rong Tan; Han Qiao; Song-Ran Liu; Ling-Long Tang; Yan-Ping Mao; Lei Chen; Wen-Fei Li; Guan-Qun Zhou; Yin Zhao; Jun-Yan Li; Qian Li; Sheng-Yan Huang; Sha Gong; Zi-Qi Zheng; Zhi-Xuan Li; Ying Sun; Wei Jiang; Jun Ma; Ying-Qin Li; Na Liu
Journal:  Nat Commun       Date:  2022-05-30       Impact factor: 17.694

Review 3.  Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer.

Authors:  Xiaolin Qu; Yongqiu Zhang; Xianzheng Sang; Ding Ren; Hong Zhao; Stephen T C Wong
Journal:  Cancers (Basel)       Date:  2022-06-29       Impact factor: 6.575

Review 4.  Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential.

Authors:  Yongfei Fan; Xinwei Li; Huihui Sun; Zhaojia Gao; Zheng Zhu; Kai Yuan
Journal:  Biomolecules       Date:  2022-09-02

5.  N6-Methyladenosine RNA Modification Landscape in the Occurrence and Recurrence of Nasopharyngeal Carcinoma.

Authors:  Yu Min Wang; Zhou Ying Peng; Lu Yuan Zhang; Ya Xuan Wang; Ruo Hao Fan; Hua Zhang; Wei Hong Jiang
Journal:  World J Oncol       Date:  2022-08-23

6.  Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer.

Authors:  Jiangchu Lei; Yuzhi Fan; Chaobiao Yan; Yeernaer Jiamaliding; Yang Tang; Jiawei Zhou; Mengna Huang; Guomin Ju; Jian Wu; Chuanhui Peng
Journal:  Front Genet       Date:  2022-09-06       Impact factor: 4.772

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.